Valiant Laboratories Approves Equity Investment in AMPYR Renewable Energy
Valiant Laboratories Ltd · Others (Uncategorized) · 17 Sept 2026, 5:43 pm
Valiant Laboratories Approves Equity Investment in AMPYR Renewable Energy Valiant Laboratories' Board approved an investment of up to ₹70 lakh in cash to acquire up to 1.01% equity and 3.60% CCPS in AMPYR Renewable Energy Resources Twelve A Private Limited. The move facilitates solar power procurement for the company's Tarapur plant under a group captive open access arrangement. The target, a subsidiary of Singapore-based AMPYR India Asset Holdings Two, reported FY25-26 turnover of ₹23.26 crore and net worth of ₹9.99 crore as of 31st Mar'26. The transaction will conclude within 12 months.
Original exchange filing (PDF)
More announcements from Valiant Laboratories Ltd
- Intimation of sad demise of the member of a Promoter Group of the Company · 16 Nov 2026
- Audited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026. · 03 Nov 2026
- Audited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026. · 03 Nov 2026
- Valiant Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 03 Nov 2026
- Valiant Laboratories Limited has informed the Exchange about Board Meeting to be held on 02-Nov-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Quarterly ended September 2026 . · 02 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 02 Nov 2026
- Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve financial results for .... · 02 Nov 2026
- Scrutinizer''s Report and Voting Results of 5th AGM of Valiant Laboratories Limited. · 29 Sept 2026
